To read the full story, subscribe or sign in.

VIRxSYS signs research agreement with National Heart, Lung, and Blood Institute

Jan. 23, 2008

BioWorld Science Endocrine/metabolic

Today's news in brief

BioWorld

BioWorld briefs for May 15, 2026.

Illustration of a glowing circle to represent circRNA

ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

BioWorld

Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...

3D illustration of adeno-associated viruses

ASGCT 2026: Uncovering the mechanisms of AAV toxicity

BioWorld

Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...

Doctor with brain illustration, businessman with dollar sign illustration

Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

BioWorld

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...

Illustration of tau accumulating in a neuron cell.

Biogen AD drug shows tau, cognition benefit, despite trial miss

BioWorld

Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...